[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Pages 69130-69131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27454]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application; 
Cerilliant Corporation

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on July 16, 2013, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, made application to the 
Drug Enforcement Administration (DEA) for registration as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methaqualone (2565)........................  I
JWH-250 (6250).............................  I
SR-18 also known as RCS-8 (7008)...........  I
XLR11 (7011)...............................  I
JWH-019 (7019).............................  I
AKB48 (7048)...............................  I
JWH-081 (7081).............................  I
SR-19 also known as RCS-4 (7104)...........  I
JWH-122 (7122).............................  I
UR-144 (7144)..............................  I
AM-2201 (7201).............................  I
JWH-203 (7203).............................  I
Parahexyl (7374)...........................  I
2C-T-2 (7385)..............................  I
JWH-398 (7398).............................  I
5-Methoxy-3,4-methylenedioxy-amphetamine     I
 (7401).
N-Hydroxy-3,4-methylenedioxy-amphetamine     I
 (7402).
Bufotenine (7433)..........................  I
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)...  I
1-(1-Phenylcyclohexyl)pyrrolidine (7470)...  I
2C-D (7508)................................  I
2C-E (7509)................................  I
2C-H (7517)................................  I
2C-I (7518)................................  I
2C-C (7519)................................  I
2C-N (7521)................................  I
2C-P (7524)................................  I
2C-T-4 (7532)..............................  I
AM-694 (7694)..............................  I
Codeine methylbromide (9070)...............  I
Acetylmethadol (9601)......................  I
Allylprodine (9602)........................  I
Alphacetylmethadol except levo-              I
 alphacetylmethadol (9603).
Alphameprodine (9604)......................  I
Alphamethadol (9605).......................  I
Benzethidine (9606)........................  I
Betacetylmethadol (9607)...................  I
Betameprodine (9608).......................  I
Betamethadol (9609)........................  I
Betaprodine (9611).........................  I
Hydroxypethidine (9627)....................  I
Noracymethadol (9633)......................  I
Norlevorphanol (9634)......................  I
Normethadone (9635)........................  I
Para-Fluorofentanyl (9812).................  I
3-Methylfentanyl (9813)....................  I
Alpha-methylfentanyl (9814)................  I
Acetyl-alpha-methylfentanyl (9815).........  I
Beta-hydroxyfentanyl (9830)................  I
Beta-hydroxy-3-methylfentanyl (9831).......  I
Alpha-methylthiofentanyl (9832)............  I
3-Methylthiofentanyl (9833)................  I
Thiofentanyl (9835)........................  I
Lisdexamfetamine (1205)....................  II
Glutethimide (2550)........................  II
Nabilone (7379)............................  II

[[Page 69131]]

 
1-Phenylcyclohexylamine (7460).............  II
1-Piperidinocyclohexane carbonitrile (8603)  II
Alphaprodine (9010)........................  II
Hydrocodone (9193).........................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Noroxymorphone (9668)......................  II
Racemethorphan (9732)......................  II
Remifentanil (9739)........................  II
Carfentanil (9743).........................  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
manufacture and distribution to their research and forensic customers 
conducting drug testing and analysis.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substance listed in schedules I and II, which fall under the authority 
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in 
the circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODW), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 18, 2013.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants 
for registration to import a basic classes of any controlled substances 
in schedules I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-27454 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P